Inibitori di pompa protonica

Terapia antiacida nel presunto reflusso gastroesofageo: un’abitudine dura a morire

E. Cacciatore, M. Mainetti, F. Marchetti

2018/7 — pag. 461-464

Terapia antiacida nel presunto reflusso gastroesofageo: un’abitudine dura a morire

E. Cacciatore, M. Mainetti, F. Marchetti

2018/7

Prescrizione di antiacidi, anti-H2 e IPP nei primi tre anni di vita nella Regione Piemonte

A. Borraccino, A. Ravaglia

2014/10 — pag. 647-651

Background - Despite the dissemination of guidelines and recommendations the treatment of gastroesophageal reflux (GER) in the paediatric population is continuously increasing. In Italy the phenomenon is still poorly documented. Objective - Aim of...

Linee guida per la diagnosi e la terapia del reflusso gastroesofageo

Sintesi a cura di R. Cavallo

2012/2 — pag. 89-98

The documents contains 24 formal recommendations deriving from a joint assessment of all the literature that can be evaluated as well as from the experience of the members of the panel and unequivocally clarifies what is useful to do, namely what i...

Indicazioni per l’utilizzo razionale dei farmaci antiacidi (anti-H2 e IPP)

F. Marchetti

2009/4 — pag. 250-254

In Italy proton pump inhibitors PPI are, certainly, too often prescribed just to prevent gastric bleedings caused by NSAIDs or steroids; besides, other drugs are prescribed to relieve symptoms or to make a diagnosis ex-juvantibus in patients with sus...